Safety profile of miltefosine in the treatment of cutaneous leishmaniasis.
Cutaneous leishmaniasis (CL) is a neglected tropical disease that poses a significant public health challenge in Brazil and worldwide. Miltefosine, the only orally administered drug available for CL, was recently incorporated into Brazil's treatment protocols following recommendations by the World H...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science (PLoS)
2024-01-01
|
| Collection: | PLoS ONE |
| Accès en ligne: | https://doi.org/10.1371/journal.pone.0315710 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|